These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23991646)

  • 1. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.
    Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK
    Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
    Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term outcomes after steatotic liver transplantation.
    Doyle MB; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Brunt EM; Chapman WC
    Arch Surg; 2010 Jul; 145(7):653-60. PubMed ID: 20644128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
    Briceño J; Padillo J; Rufián S; Solórzano G; Pera C
    Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of moderately steatotic donor liver in transplantation.
    Gao F; Xu X; Ling Q; Wu J; Zhou L; Xie HY; Wang HP; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):29-33. PubMed ID: 19208511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of steatotic donor livers on the prognosis of donors and recipients after pediatric living donor liver transplantation].
    Yang Y; Dong C; Sun C; Wang K; Zhang W; Zheng WP; Zhang FB; Qin H; Han C; Wang Z; Xu M; Gao W
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):922-929. PubMed ID: 36207981
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
    Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
    Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
    Jamieson RW; Zilvetti M; Roy D; Hughes D; Morovat A; Coussios CC; Friend PJ
    Transplantation; 2011 Aug; 92(3):289-95. PubMed ID: 21681143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding postmortem donor pool using steatotic liver grafts: a new look.
    Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
    Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of graft steatosis on liver function and organ survival after liver transplantation.
    Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
    Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of graft steatosis after liver transplantation: prospective study.
    Li J; Liu B; Yan LN; Zuo YX; Li B; Zeng Y; Zhang SF; Li FG
    Transplant Proc; 2009 Nov; 41(9):3560-3. PubMed ID: 19917344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.
    Jackson KR; Motter JD; Haugen CE; Long JJ; King B; Philosophe B; Massie AB; Cameron AM; Garonzik-Wang J; Segev DL
    Transplantation; 2020 Aug; 104(8):1604-1611. PubMed ID: 32732837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.
    Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J
    Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
    Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM
    Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
    Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
    Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.